Embedded Files
About Immunova, LLC
About Immunova, LLC
Our Mission
Immunova, LLC is a science-driven biopharmaceutical company dedicated to the discovery and development of next-generation lipid-based therapeutics. We specialize in targeting underexplored pathological mechanisms to address some of the most challenging conditions in modern medicine.
Scientific Focus
Scientific Focus
Our research is concentrated on two primary therapeutic pillars where lipid signaling and membrane dynamics play a critical role in disease progression:
CNS Pathology & Neurodegeneration
CNS Pathology & Neurodegeneration
We are developing novel interventions for neurodegenerative diseases, including Alzheimer’s Disease and Related Dementias (AD/ADRD) and Parkinson’s Disease (PD). Our pipeline also addresses the complexities of addictive diseases and aggressive CNS malignancies, such as glioma and medulloblastoma.
Metabolic & Hepatic Health
Metabolic & Hepatic Health
Immunova is pioneering treatments for liver-centric pathologies, specifically targeting fatty liver disease and Hepatocellular Carcinoma (HCC).
Furthermore, we are exploring lipid-mediated pathways to combat metabolic syndrome and obesity.
Innovation in Lipid Therapeutics
Innovation in Lipid Therapeutics
By leveraging the unique structural and signaling properties of lipids, Immunova aims to bridge the gap between discovery science and transformative clinical outcomes.
Our Team
Our Team
Brent Reynolds, PhD
Scientific Consultant
Professor of Neurosurgery University of
Florida
Brent Reynolds, PhD
Scientific Consultant
Professor of Neurosurgery University of
Florida
Stanislav Svetlov, MD/PhD
Founder
Chief Scientific Officer, Immunova,
LLC
Stanislav Svetlov, MD/PhD
Founder
Chief Scientific Officer, Immunova,
LLC
Page updated
Report abuse